Zobrazeno 1 - 10 of 266 pro vyhledávání: '"Pastano R"'
1
Akademický článek
Peripheral blood stem cell versus bone marrow graft for patients ≥60 years undergoing reduced intensity conditioning haploidentical transplantation for acute myeloid leukemia in complete remission: An analysis of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Autor: Devillier R; Transplantation and Cell Therapy Program, Institut Paoli Calmettes-Marseille, Centre de Recherche en Cancérologie de Marseille, Aix Marseille University, Marseille, France., Galimard JE; EBMT Statistical Unit, Paris, France., Blaise D; Transplantation and Cell Therapy Program, Institut Paoli Calmettes-Marseille, Centre de Recherche en Cancérologie de Marseille, Aix Marseille University, Marseille, France., Raiola AM; Ematologia e Terapie Cellulari, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Bramanti S; Transplantation Unit Department of Oncology and Haematology, IRCCS Humanitas Research Hospital, Milan, Italy., Grillo G; Department of Hematology and Bone Marrow Transplantation, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Pastano R; Onco-Haematology Division, European Institute of Oncology IRCCS, IEO, Milan, Italy., de Latour RP; Department of Hematology - BMT, Hopital St. Louis, Université de Paris Cité, Paris, France., Busca A; S.S. Trapianto di Cellule Staminali, A.O.U Citta della Salute e della Scienza di Torino, Torino, Italy., López-Corral L; Hospital Clínico, Servicio de Hematología, Salamanca, Spain., Rodríguez AB; Hospital U. Marqués de Valdecilla, Servicio de Hematología-Hemoterapia, Santander, Spain., Schmid C; Klinikum Augsburg, II Medizinische Klinik, Augsburg, Germany., Forcade E; CHU Bordeaux, Hôpital Haut-Lévêque-Pessac, Bordeaux, France., Vydra J; Institute of Hematology and Blood Transfusion, Prague, Czech Republic., Solano C; Hospital Clínico de Valencia, Servicio de Hematología-Valencia, Valencia, Spain., Bug G; Goethe-Universitaet, Medizinische Klinik II, Hämatologie, Medizinische Onkologie, Frankfurt-Main, Germany., Neubauer A; Philipps Universitaet Marburg, University Hospital Giessen and Marburg, Marburg, Germany., Charbonnier A; University of Amiens: CHU Amiens, Service d'Hematologie, Amiens, France., Brissot E; Saint Antoine University Hospital, Paris, France., Nagler A; Hematology Division, Chaim Sheba Medical Center, Tel-Hashomer, Israel., Ciceri F; IRCCS Ospedale San Raffaele, Milan, Italy., Mohty M; Saint Antoine University Hospital, Paris, France.
Publikováno v: American journal of hematology [Am J Hematol] 2024 Jul; Vol. 99 (7), pp. 1250-1256. Date of Electronic Publication: 2024 May 23.
Zobrazit plný text záznamu
2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
3
Akademický článek
Hematological disorders after salvage PARPi treatment for ovarian cancer: Cytogenetic and molecular defects and clinical outcomes.
Autor: Todisco E; Onco-Hematology Division, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Ospedale di Busto Arsizio, ASST Valle Olona, Busto Arsizio, Italy., Gigli F; Onco-Hematology Division, IEO, European Institute of Oncology IRCCS, Milan, Italy., Ronchini C; Laboratory of Clinical Genomics, IEO, European Institute of Oncology IRCCS, Milan, Italy., Amato V; Onco-Hematology Division, IEO, European Institute of Oncology IRCCS, Milan, Italy., Sammassimo S; Onco-Hematology Division, IEO, European Institute of Oncology IRCCS, Milan, Italy., Pastano R; Onco-Hematology Division, IEO, European Institute of Oncology IRCCS, Milan, Italy., Parma G; Department of Gynecology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Lapresa MT; Department of Gynecology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Bertolini F; Laboratory of Hematology-Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Corsini C; Laboratory of Hematology-Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Gregato G; Laboratory of Hematology-Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Poletti C; Laboratory of Hematology-Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Pelicci PG; Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Alcalay M; Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Colombo N; Department of Gynecology, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Gynecologic Cancer Program, European Institute of Oncology IRCCS and University of Milan-Bicocca, Milan, Italy., Tarella C; Onco-Hematology Division, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Department of Health Sciences, University of Milan, Milan, Italy.
Publikováno v: International journal of cancer [Int J Cancer] 2022 Nov 15; Vol. 151 (10), pp. 1791-1803. Date of Electronic Publication: 2022 Jul 02.
Zobrazit plný text záznamu
4
Akademický článek
Outcome of allogeneic transplantation for mature T-cell lymphomas: impact of donor source and disease characteristics.
Autor: Hamadani M; BMT and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI., Ngoya M; European Society for Blood and Marrow Transplantation, Paris, France., Sureda A; Clinical Hematology Department, Catalan Institute of Oncology, Institut d'Investigació Biomèdica de Bellvitge IDIBELL, Universitat de Barcelona, Barcelona, Spain., Bashir Q; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX., Litovich CA; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI., Finel H; European Society for Blood and Marrow Transplantation, Paris, France., Chen Y; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI., Boumendil A; European Society for Blood and Marrow Transplantation, Paris, France., Zain J; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, CA., Castagna L; BMT Unit, Humanitas Clinical and Research Center-IRCCS, Humanitas Cancer Center, Milan, Italy., Cashen AF; Division of Oncology, Section of Stem Cell Transplantation, Washington University School of Medicine, St. Louis, MO., Blaise D; Transplant and Cellular Immunotherapy Program, Department of Hematology, Institut Paoli-Calmettes, Aix Marseille University, CNRS, INSERM, CRCM, Marseille, France., Shadman M; Department of Medicine, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA., Pastano R; Onco-Hematology Division, Bone Marrow Transplant Unit, European Institute of Oncology, IRCCS, Milan, Italy., Khimani F; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL., Arat M; Istanbul Florence Nightingale Hospital, Hematology and HSCT Unit, Istanbul, Turkey., Dietrich S; Department of Medicine V, University of Heidelberg, Heidelberg, Germany., Schmitz N; Department of Medicine A, Haematology, and Oncology, University Hospital Münster, Münster, Germany., Glass B; European Society for Blood and Marrow Transplantation, Paris, France.; Department of Hematology and Cell Therapy, Helios Klinikum Berlin-Buch, Berlin, Germany., Kharfan-Dabaja MA; Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapies Program, Mayo Clinic, Jacksonville, FL., Corradini P; Department of Oncology and Hematology, Fonzazione Istituto Nazionale dei Tumori, University of Milano, Milano, Italy., Sauter CS; Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY., Montoto S; Department of Haemato-oncology, St. Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom; and., Kwon M; Department of Hematology, Gregorio Marañón General University Hospital, Institute of Health Research Gregorio Marañon, Madrid, Spain., Herrera AF; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, CA., Dreger P; Department of Medicine V, University of Heidelberg, Heidelberg, Germany.
Publikováno v: Blood advances [Blood Adv] 2022 Feb 08; Vol. 6 (3), pp. 920-930.
Zobrazit plný text záznamu
5
Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey
Autor: Girmenia, C, Bertaina, A, Piciocchi, A, Perruccio, K, Algarotti, A, Busca, A, Cattaneo, C, Raiola, Am, Guidi, S, Iori, Ap, Candoni, A, Irrera, G, Milone, G, Marcacci, G, Scimè, R, Musso, M, Cudillo, L, Sica, S, Castagna, L, Corradini, P, Marchesi, F, Pastore, D, Alessandrino, Ep, Annaloro, C, Ciceri, F, Santarone, S, Nassi, L, Farina, C, Viscoli, C, Rossolini, Gm, Bonifazi, F, Rambaldi, A, Capria, S, Mastronuzzi, A, Pagliara, D, Bernaschi, P, Amico, L, Carotti, A, Mencacci, A, Bruno, B, Costa, C, Passi, A, Ravizzola, G, Angelucci, E, Marchese, A, Pecile, P, Ventura, G, Fanin, R, Scarparo, C, Barbaro, A, Leotta, S, Marchese, Ae, Becchimanzi, C, Donnarumma, D, Tringali, S, Baldi, Mt, Scalone, R, Picardi, A, Arcese, W, Fontana, C, Giammarco, S, Spanu, T, Crocchiolo, R, Casari, E, Mussetti, A, Conte, E, Ensoli, F, Miragliotta, G, Marone, P, Arghittu, M, Greco, R, Forcina, A, Chichero, P, Di Bartolomeo, P, Fazii, P, Kroumova, V, Decembrino, N, Zecca, M, Pisapia, G, Palazzo, G, Lanino, E, Faraci, M, Castagnola, E, Bandettini, R, Pastano, R, Sammassimo, S, Passerini, R, Stefani, Pm, Gherlinzoni, F, Rigoli, R, Prezioso, L, Cambò, B, Calderaro, A, Carella, Am, Cascavilla, N, Labonia, Mt, Celeghini, I, Mordini, N, Piana, F, Vacca, A, Sanna, M, Podda, G, Corsetti, Mt, Rocchetti, A, Cilloni, D, De Gobbi, M, Bianco, O, Fagioli, F, Carraro, F, De Intinis, G, Severino, A, Proia, A, Parisi, G, Vallisa, D, Confalonieri, M, Russo, D, Malagola, M, Galieni, P, Falcioni, S, Travaglini, V, Raimondi, R, Borghero, C, Pavan, G, Prete, A, Belotti, T, Ambretti, S, Imola, M, Mianulli, Am, Pedna, Mf, Cesaro, S, Lo Cascio, G, Ferrari, A, Piedimonte, M, Santino, I, Calandrelli, M, Olivieri, A, Orecchioni, F, Mirabile, M, Centurioni, R, Gironacci, L, Caravelli, D, Gallo, S, De Filippi, M, Cupelli, L, Dentamaro, T, Falco, S, Eugenio, Os, Marotta, S, Risitano, A, Lula, D, Musto, P, Pietrantuono, G, Traficante, A, Cerchiara, E, Tirindelli, Mc, Dicuonzo, G, Chierichini, A, Anaclerico, B, Placanica, P.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3662::54e9a93d3d03680bb5cb7e8637e911b1
http://hdl.handle.net/11379/498312
Zobrazit plný text záznamu
6
Report
Pre-existing immune checkpoints activation predicts relapse after allogeneic stem cell transplantation in lymphoma.
Autor: Derenzini E; Oncohematology Division, IEO European Institute of Oncology IRCCS, Milan, Italy. enrico.derenzini@ieo.it.; Department of Health Sciences, University of Milan, Milan, Italy. enrico.derenzini@ieo.it., Tabanelli V; Haemolymphopathology Division, IEO European Institute of Oncology IRCCS, Milan, Italy., Sammassimo S; Oncohematology Division, IEO European Institute of Oncology IRCCS, Milan, Italy., Mazzara S; Haemolymphopathology Division, IEO European Institute of Oncology IRCCS, Milan, Italy., Motta G; Haemolymphopathology Division, IEO European Institute of Oncology IRCCS, Milan, Italy., Melle F; Haemolymphopathology Division, IEO European Institute of Oncology IRCCS, Milan, Italy., Vanazzi A; Oncohematology Division, IEO European Institute of Oncology IRCCS, Milan, Italy., Calleri A; Haemolymphopathology Division, IEO European Institute of Oncology IRCCS, Milan, Italy., Fiori S; Haemolymphopathology Division, IEO European Institute of Oncology IRCCS, Milan, Italy., Finazzi MC; Hematology and Bone marrow Transplant Unit, ASST-Papa Giovanni XXIII, Bergamo, Italy., Barbanti MC; Hematology and Bone marrow Transplant Unit, ASST-Papa Giovanni XXIII, Bergamo, Italy., Ramadan S; Oncohematology Division, IEO European Institute of Oncology IRCCS, Milan, Italy., Gandini S; Molecular and Pharmaco-Epidemiology Unit, Department of Experimental Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy., Pastano R; Oncohematology Division, IEO European Institute of Oncology IRCCS, Milan, Italy., Rambaldi A; Hematology and Bone marrow Transplant Unit, ASST-Papa Giovanni XXIII, Bergamo, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Pileri S; Haemolymphopathology Division, IEO European Institute of Oncology IRCCS, Milan, Italy., Tarella C; Oncohematology Division, IEO European Institute of Oncology IRCCS, Milan, Italy. corrado.tarella@ieo.it.; Department of Health Sciences, University of Milan, Milan, Italy. corrado.tarella@ieo.it.
Publikováno v: Bone marrow transplantation [Bone Marrow Transplant] 2021 Sep; Vol. 56 (9), pp. 2280-2283. Date of Electronic Publication: 2021 May 07.
Zobrazit plný text záznamu
7
Akademický článek
Clinical presentation, diagnosis and management of therapy-related hematological disorders in women with epithelial ovarian cancer treated with chemotherapy and poly-ADP-ribose polymerase inhibitors: A single-center experience.
Autor: Todisco E; Onco-Hematology Division, IEO, European Institute of Oncology IRCCS, Milan, Italy., Gigli F; Onco-Hematology Division, IEO, European Institute of Oncology IRCCS, Milan, Italy., Mantiero M; Gynecologic Oncology Unit, Fondazione IRCCS National Cancer Institute, Milan, Italy., Sammassimo S; Onco-Hematology Division, IEO, European Institute of Oncology IRCCS, Milan, Italy., Pastano R; Onco-Hematology Division, IEO, European Institute of Oncology IRCCS, Milan, Italy., Ronchini C; Laboratory of Clinical Genomics, IEO, European Institute of Oncology IRCCS, Milan, Italy., Parma G; Department of Gynecology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Lapresa MT; Department of Gynecology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Iori AP; Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy., Bertolini F; Laboratory of Hematology-Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Corsini C; Laboratory of Hematology-Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Gregato G; Laboratory of Hematology-Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Poletti C; Laboratory of Hematology-Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Colombo N; Gynecologic Cancer Program, European Institute of Oncology and University of Milan-Bicocca, Milan, Italy., Tarella C; Onco-Hematology Division, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Department of Health Sciences, University of Milan, Milan, Italy.
Publikováno v: International journal of cancer [Int J Cancer] 2021 Jan 01; Vol. 148 (1), pp. 170-177. Date of Electronic Publication: 2020 Sep 16.
Zobrazit plný text záznamu
9
Editorial & Opinion
Efficacy of venetoclax based salvage chemotherapy followed by "Minimal Residual Disease driven"-venetoclax maintenance therapy post-allotransplant in a young patient with high risk primary refractory acute myeloid leukemia.
Autor: Todisco E; Onco-hematology Division, IEO, European Institute of Oncology IRCCS, Milano, Italy., Gigli F; Onco-hematology Division, IEO, European Institute of Oncology IRCCS, Milano, Italy., Sammassimo S; Onco-hematology Division, IEO, European Institute of Oncology IRCCS, Milano, Italy., Camisaschi C; Laboratory of Hematology-Oncology, IEO, European Institute of Oncology IRCCS, Milano, Italy., Mancuso P; Laboratory of Hematology-Oncology, IEO, European Institute of Oncology IRCCS, Milano, Italy., Ronchini C; Laboratory of Clinical Genomics, IEO, European Institute of Oncology IRCCS, Milano, Italy., Ramadan S; Onco-hematology Division, IEO, European Institute of Oncology IRCCS, Milano, Italy., Bertolini F; Laboratory of Hematology-Oncology, IEO, European Institute of Oncology IRCCS, Milano, Italy., Pastano R; Onco-hematology Division, IEO, European Institute of Oncology IRCCS, Milano, Italy., Tarella C; Onco-hematology Division, IEO, European Institute of Oncology IRCCS, Milano, Italy.; Department of Health Sciences, University of Milan, Milano, Italy.
Publikováno v: Leukemia & lymphoma [Leuk Lymphoma] 2020 Sep; Vol. 61 (9), pp. 2277-2279. Date of Electronic Publication: 2020 May 02.
Zobrazit plný text záznamu
10
Akademický článek
Nonmyeloablative Alternative Donor Transplantation for Hodgkin and Non-Hodgkin Lymphoma: From the LWP-EBMT, Eurocord, and CIBMTR.
Autor: Fatobene G; Hospital das Clínicas and LIM31, Faculty of Medicine, University of São Paulo, São Paulo, Brazil.; Hospital Sírio-Libanês, São Paulo, Brazil., Rocha V; Hospital das Clínicas and LIM31, Faculty of Medicine, University of São Paulo, São Paulo, Brazil.; Churchill Hospital, Oxford, United Kingdom., St Martin A; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI., Hamadani M; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI., Robinson S; University Hospitals Bristol National Health Service (NHS) Foundation Trust, Bristol, United Kingdom., Bashey A; The Blood and Marrow Transplant Program, Northside Hospital, Atlanta, GA., Boumendil A; European Society for Blood and Marrow Transplantation Paris Study Office/European Center for Biostatistical and Epidemiological Evaluation in Hematopoietic Cell Therapy, Paris, France., Brunstein C; University of Minnesota Medical Center, Minneapolis, MN., Castagna L; Istituto Clinico Humanitas, Rozzano Milano, Italy., Dominietto A; IRCCS Ospedale Policlinico San Martino, Genova, Italy., Finel H; European Society for Blood and Marrow Transplantation Paris Study Office/European Center for Biostatistical and Epidemiological Evaluation in Hematopoietic Cell Therapy, Paris, France., Chalandon Y; Division of Hematology, Hôpitaux Universitaires of Geneva, Faculty of Medicine, University of Geneva, Geneva and Swiss Cancer Center Leman, Switzerland., Kenzey C; Eurocord, Université de Paris, Institut de Recherche de Saint-Louis (IRSL) EA3518, Paris, France., Kharfan-Dabaja M; Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL., Labussière-Wallet H; Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Lyon, France., Moraleda JM; Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain., Pastano R; European Institute of Oncology, Milano, Italy., Perales MA; Memorial Sloan Kettering Cancer Center, New York, NY., El Ayoubi HR; Eurocord, Université de Paris, Institut de Recherche de Saint-Louis (IRSL) EA3518, Paris, France., Ruggeri A; Department of Pediatric Hematology and Oncology, Istituto di Ricovero e Cura a Carattere Scientifico, Ospedale Pediatrico Bambino Gesù, Roma, Italy., Sureda A; Clinical Hematology Department, Institut Català d'Oncxologia - Hospitalet, IDIBELL, Universitat de Barcelona, Barcelona, Spain., Volt F; Eurocord, Université de Paris, Institut de Recherche de Saint-Louis (IRSL) EA3518, Paris, France., Yakoub-Agha I; CHU de Lille, LIRIC, INSERM U995, Université de Lille, Lille, France., Zhang MJ; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.; Division of Biostatistics, Institute for Health and Society, Medical College of Wisconsin, Milwaukee, WI., Gluckman E; Eurocord, Université de Paris, Institut de Recherche de Saint-Louis (IRSL) EA3518, Paris, France.; Monacord, Centre Scientifique de Monaco, Monaco., Montoto S; Department of Haemato-Oncology, St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom., Eapen M; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.
Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2020 May 10; Vol. 38 (14), pp. 1518-1526. Date of Electronic Publication: 2020 Feb 07.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje